What class of drug is cosentyx?

What class of medicine is Cosentyx (secukinumab)?

Cosentyx (secukinumab) is a biologic medicine in the class of monoclonal antibodies. It specifically targets interleukin-17A (IL-17A), a protein involved in inflammatory pathways that drive conditions like plaque psoriasis and other inflammatory diseases.

What does it target in the immune system?

Cosentyx works by binding to IL-17A, helping reduce inflammation by interrupting signaling that contributes to the symptoms of immune-mediated diseases.

What conditions is this drug used for (same drug class)

Because it is an IL-17A–blocking monoclonal antibody, Cosentyx is used for several IL-17A–driven inflammatory conditions, including plaque psoriasis and psoriatic arthritis (the drug’s indications depend on the country and product labeling).